Business Description
Kiromic BioPharma Inc
NAICS : 541714
SIC : 2833
ISIN : US4976342042
Share Class Description:
KRBP: Ordinary SharesDescription
Kiromic BioPharma Inc is a biotechnology company. It is an artificial intelligence (AI) driven, end-to-end allogeneic cell therapy company, currently developing the multi-indication allogeneic T cell therapy that exploits the natural potency of the Gamma Delta T cell (GDT) to target solid tumors. The company is a gene-editing which utilizes artificial intelligence and a proprietary neural network platform with a therapeutic focus on immuno-oncology.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.21 | |||||
| Equity-to-Asset | -0.75 | |||||
| Debt-to-Equity | -1.7 | |||||
| Debt-to-EBITDA | -0.92 | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 50.5 | |||||
| 3-Year EPS without NRI Growth Rate | 56.4 | |||||
| 3-Year FCF Growth Rate | 27.2 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 47.75 | |||||
| 9-Day RSI | 48.46 | |||||
| 14-Day RSI | 49.53 | |||||
| 6-1 Month Momentum % | 1104 | |||||
| 12-1 Month Momentum % | -26.59 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.22 | |||||
| Quick Ratio | 0.22 | |||||
| Cash Ratio | 0.16 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -72.7 | |||||
| Shareholder Yield % | -242.21 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROA % | -160.86 | |||||
| ROIC % | -102.68 | |||||
| ROC (Joel Greenblatt) % | -213.61 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -0.82 | |||||
| EV-to-Forward-EBIT | -0.14 | |||||
| EV-to-EBITDA | -0.93 | |||||
| EV-to-Forward-EBITDA | -0.14 | |||||
| EV-to-FCF | -0.74 | |||||
| Earnings Yield (Greenblatt) % | -121.95 | |||||
| FCF Yield % | -633.77 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:KRBP
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Kiromic BioPharma Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -15.07 | ||
| Beta | 2.39 | ||
| Volatility % | 304.72 | ||
| 14-Day RSI | 49.53 | ||
| 14-Day ATR ($) | 0.379789 | ||
| 20-Day SMA ($) | 2.747025 | ||
| 12-1 Month Momentum % | -26.59 | ||
| 52-Week Range ($) | 0.16 - 8.97 | ||
| Shares Outstanding (Mil) | 1.29 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Kiromic BioPharma Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Kiromic BioPharma Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Kiromic BioPharma Inc Frequently Asked Questions
What is Kiromic BioPharma Inc(KRBP)'s stock price today?
The current price of KRBP is $2.60. The 52 week high of KRBP is $8.97 and 52 week low is $0.16.
When is next earnings date of Kiromic BioPharma Inc(KRBP)?
The next earnings date of Kiromic BioPharma Inc(KRBP) is 2024-05-15 Est..
Does Kiromic BioPharma Inc(KRBP) pay dividends? If so, how much?
Kiromic BioPharma Inc(KRBP) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers